22 / 24
22
noviembre
2016.
Volumen
15
-
N
°
66
1.-
Mallol J., Cortez E., Amarales L., et al. The Global StrategyforAsthma Management and Prevention
2016
. Prevalencia de asma en escolares chilenos. Estudio
descriptivo de
24470
niños ISSAC- Chile. Rev Médica de Chile
2000; 128: 279-285.
2.-
Mackenney P. Asma en Pediatría. Revista Clínica Las Condes
2007
.
3.-
Ponte EV, Cruz AA, Athanazio R, Carvalho-Pinto R, Fernandes FL, Barreto ML, Stelmach R. Urbanization is associated with increase dasthma morbidity and
mortality in Brazil. ClinRespir J.
2016
Jul
12
. Doi:
10.111
/crj.
12530
.
4.-
Velástegui C., Pérez-Canto P., Zárate V., Arenas D., Salinas P., Moreno G., Prado F. Impact of asthma among primary attention children. RevMedChil.
2010
Feb;
138(2):205-12.
5.-
M.L. Garcia-Garcia et al. Asma y virus en el niño. ArchBronconeumol.
2016;52(5):269–273.
6.-
Nievas IF, Anand KJ. Severe acute asthma exacerbation in children: a stepwise approach for escalating therapy in a pediatricintensive care unit. J
PediatrPharmacolTher.
2013
Apr;
18
(
2
):
88-104.
doi:
10.5863/1551-6776-18.2.88.
7.-
Jones BP; Paul A. Management of acuteasthma in thepediatricpatient: Anevidence-basedreview. PediatrEmergMedPract.
2013
May;
10 (5):1-23.
8.-
Wong JJ, Lee JH, Turner DA, Rehder KJ. A review of the use of adjunctive therapies in severe acute asthma exacerbation in critically ill children Expert Rev
Respir Med.
2014
Aug;
8(4):423-41
.
9.-
Pardue Jones B, Fleming GM, Otillio JK, Asokan I, Arnold DH. Pediatric acute asthm exacerbations: Evaluation and management from emergency department
to intensivecare unit. J Asthma.
2016
Aug;
53
(
6):607-17.
10.-
Griffiths B, Ducharme FM. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Cochrane
DatabaseSyst Rev.
2013
Aug
21;(8).
11.-
Vézina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta (
2
)-agonists versus short-acting beta
2
-agonists aloneforchildren with
acute asthma in hospital. Cochrane DatabaseSyst Rev.
2014
Jul
31;(7)
.
12.-
Mikalsen IB, Davis P, Øymar K. High flow nasal cannula in children: a literature review. Scand J Trauma ResuscEmergMed.
2016
Jul
12;24(1):93.
13.-
De Pedro J, Martínez-Mujica O, Ballestero Y, Portillo N, Arana E, Benito J. Ensayo Clínico piloto del uso de oxígeno de alto flujo en niños con asma en un
servicio de urgencias pediátrico. Hospital Universitario Cruces. XX Reunión Anual de la Sociedad Española de Urgencia de Pediatría.
16
a
18
de Abril
2015
.
14.-
Kelly GS, Simon HK, Sturm JJ. High-flow nasal cannula use in children with respiratory distress in the emergency department: predicting the need for
subsequent intubation. PediatrEmergCare.
2013
Aug;
29(8):888-92.
15.-
Frat JP, Brugiere B, Ragot S, Chatellier D, Veinstein A, Goudet V, Coudroy R, Petitpas F, Robert R, Thille AW, Girault C. Sequential application of oxygen therapy
via high-flow nasal cannula and noninvasive ventilation in acuterespiratory failure: an observational pilot study. RespirCare.
2015
Feb;
60(2):170-8.
16.-
Akingbola OA, Simakajornboon N, HadleyJr EF, Hopkins RL. Noninvasive positive-pressureventilation in pediatric status asthmaticus. PediatrCritCareMed.
2002
Apr;
3(2):181-184.
17.-
Carroll CL, Schramm CM. Noninvasive positive pressureventilationforthetreatment of status asthmaticus in children. Ann Allergy Asthma Immunol.
2006
Mar;
96(3):454-9
.
18.-
Basnet S, Mander G, Andoh J, Klaska H, Verhulst S, Koirala J. Safety, efficacy, and tolerability of earlyinitiation of noninvasive positive pressureventilation in
pediatricpatientsadmittedwith status asthmaticus: a pilotstudy. PediatrCritCareMed.
2012
Jul;
13(4):393-8.
19.-
Williams AM, Abramo TJ, Shah MV, Miller RA, Burney-Jones C, Rooks S, Estrada C, Arnold DH. Safety and clinicalfindings of BiPAP utilization in children
20
kg
or less for asthma exacerbations. IntensiveCareMed.
2011
Aug;
37(8):1338-43.
20.-
Paula de Souza Silva, Menna Barreto SS. Noninvasiveventilation in status asthmaticus in children: levels of evidence. RevBras TerIntensiva.
2015
Oct-Dec;
27(4):390-396.
21.-
Dhand R. Aerosol therapy in patients receiving non invasive positive pressure ventilation. J Aerosol MedPulmDrugDeliv.
2012
Apr;
25(2):63-78
.
22.-
Galindo-Filho VC, Brandão DC, Ferreira Rde C, Menezes MJ, Almeida-Filho P, Parreira VF, Silva TN, Rodrigues-Machado Mda G, Dean E, Dornelas de Andrade A.
Non invasive ventilation coupled with nebulization during asthma crises: a randomized controlled trial. RespirCare
2013; 58 (2): 241-249
.
23.-
Hess DR. Aerosol Therapy During NoninvasiveVentilation or High-Flow Nasal Cannula. RespirCare.
2015
Jun;
60(6):880-91
.
24.-
Ohn M, Jacobe S. Magnesium should be given toall children presenting to hospital with acute severe asthma.PaediatrRespir Rev.
2014
Dec;
15(4):319-21.
25.-
Griffiths B, Kew KM. Intravenous magnesium sulfate for treating children with acute asthma in the emergencydepartment. Cochrane DatabaseSyst Rev.
2016
Apr
29;4:CD011050.
26.-
Irazuzta JE, Paredes F, Pavlicich V, Domínguez SL. High Dose Magnesium Sulfate Infusion for Severe Asthma in the Emergency Department: Efficacy Study.
PediatrCritCareMed.
2016
Feb;
17(2
):e
29-33
.
Referencias: